Metformin, insulin sensitizing drug, potentiated the therapeutic efficacy of hASCs in HFD-diabetic mice as shown by enhanced reversal of hyperglycemia, hyperinsulinemia and triglyceridemia [99]. The gene discussed is INS; the disease is Hyperglycemia.